chr10-43111393-A-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_020975.6(RET):​c.1450A>G​(p.Met484Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000483 in 1,447,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M484T) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 34)
Exomes š‘“: 0.0000048 ( 0 hom. )

Consequence

RET
NM_020975.6 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.600

Publications

1 publications found
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
RET Gene-Disease associations (from GenCC):
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • multiple endocrine neoplasia type 2A
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • multiple endocrine neoplasia type 2B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Hirschsprung disease, susceptibility to, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Haddad syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.036875725).
BP6
Variant 10-43111393-A-G is Benign according to our data. Variant chr10-43111393-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 579366.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020975.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
NM_020975.6
MANE Select
c.1450A>Gp.Met484Val
missense
Exon 7 of 20NP_066124.1P07949-1
RET
NM_001406743.1
c.1450A>Gp.Met484Val
missense
Exon 7 of 21NP_001393672.1P07949-1
RET
NM_001406744.1
c.1450A>Gp.Met484Val
missense
Exon 7 of 20NP_001393673.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
ENST00000355710.8
TSL:5 MANE Select
c.1450A>Gp.Met484Val
missense
Exon 7 of 20ENSP00000347942.3P07949-1
RET
ENST00000340058.6
TSL:1
c.1450A>Gp.Met484Val
missense
Exon 7 of 19ENSP00000344798.4P07949-2
RET
ENST00000713926.1
c.1321A>Gp.Met441Val
missense
Exon 7 of 19ENSP00000519223.1A0AAQ5BH28

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD2 exomes
AF:
0.00000796
AC:
2
AN:
251234
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000483
AC:
7
AN:
1447900
Hom.:
0
Cov.:
58
AF XY:
0.00000417
AC XY:
3
AN XY:
720126
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33022
American (AMR)
AF:
0.00
AC:
0
AN:
44296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25640
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38918
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86122
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5688
European-Non Finnish (NFE)
AF:
0.00000635
AC:
7
AN:
1103176
Other (OTH)
AF:
0.00
AC:
0
AN:
59416
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
1
-
Multiple endocrine neoplasia type 2A;C0025269:Multiple endocrine neoplasia type 2B;C0031511:Pheochromocytoma;C1833921:Familial medullary thyroid carcinoma;C3888239:Hirschsprung disease, susceptibility to, 1 (1)
-
1
-
Multiple endocrine neoplasia, type 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
5.3
DANN
Benign
0.37
DEOGEN2
Benign
0.40
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.037
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.34
N
PhyloP100
0.60
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-0.70
N
REVEL
Benign
0.13
Sift
Benign
0.66
T
Sift4G
Benign
0.53
T
Polyphen
0.0
B
Vest4
0.044
MutPred
0.34
Loss of phosphorylation at Y483 (P = 0.1884)
MVP
0.46
MPC
0.20
ClinPred
0.026
T
GERP RS
2.0
Varity_R
0.095
gMVP
0.31
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs755660496; hg19: chr10-43606841; API